Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Fast Is The Neurological Biomarkers Market Expected to Grow Between 2025 And 2029?#_x000D_

The market size for neurological biomarkers has seen significant expansion in the past few years. The market value that stood at $10.7 billion in 2024 is expected to rise to $11.92 billion in 2025, representing a compound annual growth rate (CAGR) of 11.4%. The surge seen in the historic period can be credited to factors such as ascending prevalence of neurological disorders, growing aging population, necessities in drug development, amplified financing for neurological study, and personalized medicine._x000D_

_x000D_

The market for neurological biomarkers is projected to experience a fast-paced escalation in the foreseeable future, growing to$19.91 billion by 2029 at a compound annual growth rate (CAGR) of 13.7%. This anticipated growth in the forecast period can primarily be traced back to the advent of biomarkers for early detection, the use of biosensors and wearable devices, the launch of global health initiatives, and a patient-centric approach. Some significant trends to watch out for during the forecast period include the advent of innovative imaging technology, quick progress in omics technologies, the incorporation of artificial intelligence (AI), application of real-world evidence in validating biomarkers, enhancements in diagnostic technologies, and growing collaborations between industry and research bodies._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=12677&type=smp_x000D_

_x000D_

#What Are the Major Market Drivers Behind the Rising Adoption of Neurological Biomarkers Market?#_x000D_

The rise in neurological disorders is anticipated to fuel the growth of the neurological biomarker market in the future. Neurological diseases impact the brain, spinal cord, and the body’s remaining nerves. Parkinson’s disease, a neurodegenerative condition, affects the neurological system and the regions of the body under nerve control. Neurological biomarkers assist in the early detection of Parkinson’s disease with the use of pathological, biochemical, and genetic tests. For example, in December 2022, the Parkinson’s Foundation, a non-profit organization based in the US, reported that the number of new Parkinson’s disease cases rose to 90,000 in 2022, a significant increase from 60,000 annually in 2021. Thus, the escalating incidence of neurological disorders is leading to the expansion of the neurological biomarker market._x000D_

_x000D_

#Which Key Market Segments Comprise the Neurological Biomarkers Market and Drive Its Revenue Growth?#_x000D_

The neurological biomarkersmarket covered in this report is segmented – _x000D_

_x000D_

1) By Product: Proteomics Biomarker; Genomics Biomarker; Metabolomics Biomarker; Imaging Biomarker; Other Products_x000D_

2) By Application: Alzheimer’s Disease; Parkinson’s Disease; Huntington’s Disease; Schizophrenia; Depression; Multiple Sclerosis; Spinal Muscular Atrophy_x000D_

3) By End-User: Hospital Laboratories; Clinical Diagnostic Centers; Research Organizations; Other End-Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Proteomics Biomarker: Protein Biomarkers; Antibody Biomarkers _x000D_

2) By Genomics Biomarker: DNA Biomarkers; RNA Biomarkers _x000D_

3) By Metabolomics Biomarker: Metabolite Biomarkers; Lipid Biomarkers _x000D_

4) By Imaging Biomarker: MRI Biomarkers; PET Scan Biomarkers _x000D_

5) By Other Products: Neuroinflammatory Biomarkers; Neurotransmitter Biomarkers _x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=12677&type=smp_x000D_

_x000D_

#Which Areas Are Leading Regions in the Neurological Biomarkers Market Expansion Across the Globe?#_x000D_

North America was the largest region in the neurological biomarkers market in 2024. The regions covered in the neurological biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa _x000D_

_x000D_

#What Are the Strategic Trends Steering theNeurological Biomarkers Market Direction?#_x000D_

Key players in the neurological biomarkers industry are banding together to create new products and consolidate their market positions. The neurological biomarkers market is spurred by these alliances and partnerships, which encourage ingenuity, utilize collective knowledge, and speed up the creation and marketing of sophisticated treatments by joining forces and abilities. For instance, in July 2022, NeuroSense Therapeutics Ltd., an Israel-based company focused on the research of serious neurodegenerative diseases, teamed up with NeuraLight, a company also based in Israel concentrating on creating objective and delicate biomarkers for neurological diseases. The joint venture aims to detect oculometric markers for Amyotrophic Lateral Sclerosis (ALS) using AI (Artificial Intelligence) and ML (Machine Learning). This alliance follows NeuraLight’s successful $25 million Series A funding round and aims to promote the recognition and use of digital ALS markers in a corresponding study. It represents the first clinical trial by the collaboration. The partnership focuses on the employment of oculometric digital markers, which could facilitate patient categorization and improve the success rate of clinical trials._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/neurological-biomarkers-global-market-report_x000D_

_x000D_

#How Is the Neurological Biomarkers Market Conceptually Defined?#_x000D_

A neurological biomarker is a substance that provides objective and quantifiable information about the presence, progression, or characteristics of a neurological disorder or condition. They are used in clinical practice during drug development._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12677_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model